Form UPLOAD - SEC-generated letter:
SEC Accession No. 0000000000-20-008268
Filing Date
2020-09-02
Accepted
2020-09-02 11:37:24
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.pdf LETTER 31617
2 filename2.txt TEXT-EXTRACT 7544
  Complete submission text file 0000000000-20-008268.txt   51673
Mailing Address 7318 MORTON STREET DALLAS TX 75209
Business Address 7318 MORTON STREET DALLAS TX 75209 212.551.8702
Taysha Gene Therapies, Inc. (Filed for) CIK: 0001806310 (see all company filings)

EIN.: 843199512 | State of Incorp.: DE | Fiscal Year End: 1231
Type: UPLOAD
SIC: 2836 Biological Products, (No Diagnostic Substances)